-
Signature
-
/s/ Christopher Bedi by Russell S. Elmer, Attorney-in-Fact
-
Stock symbol
-
NOW
-
Transactions as of
-
May 12, 2023
-
Transactions value $
-
-$540,010
-
Form type
-
4
-
Date filed
-
5/16/2023, 08:07 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
NOW |
Common Stock |
Options Exercise |
$0 |
+137 |
+0.87% |
$0.00 |
15.9K |
May 12, 2023 |
Direct |
|
transaction |
NOW |
Common Stock |
Tax liability |
-$31K |
-68 |
-0.43% |
$455.20 |
15.9K |
May 12, 2023 |
Direct |
F1 |
transaction |
NOW |
Common Stock |
Sale |
-$10.4K |
-23 |
-0.15% |
$453.30 |
15.8K |
May 15, 2023 |
Direct |
F2 |
transaction |
NOW |
Common Stock |
Options Exercise |
$82.5K |
+1.1K |
+6.95% |
$74.97 |
16.9K |
May 15, 2023 |
Direct |
F2 |
transaction |
NOW |
Common Stock |
Sale |
-$499K |
-1.1K |
-6.5% |
$453.30 |
15.8K |
May 15, 2023 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
NOW |
Restricted Stock Units |
Options Exercise |
$0 |
-137 |
-8.36% |
$0.00 |
1.5K |
May 12, 2023 |
Common Stock |
137 |
|
Direct |
F3, F4 |
transaction |
NOW |
Employee Stock Option (Right to Buy) |
Options Exercise |
-$82.5K |
-1.1K |
-15.49% |
$74.97 |
6K |
May 15, 2023 |
Common Stock |
1.1K |
$74.97 |
Direct |
F2, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: